Cardiovalve Completes Enrollment for CE Registration of TTVR System Venus Medtech's Cardiovalve has finished enrolling 150 patients for the TARGET study, pushing towards CE Mark approval for its TTVR system, with commercial launch slated for 2027.

Cardiovalve Completes Enrollment for CE Registration of TTVR System #China #Hangzhou #Venus_Medtech #Cardiovalve #TTVR_System

Laplace Interventional Advances Heart Valve Treatment with New Delivery Methods Laplace Interventional completes early feasibility study and unveils new delivery methods for its transcatheter tricuspid valve replacement system.

Laplace Interventional Advances Heart Valve Treatment with New Delivery Methods #USA #Minnesota #Laplace_Interventional #Transcatheter #TTVR_System